Page last updated: 2024-12-11
amphidinolide c
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
amphidinolide C: a potent cytotoxic 25-membered macrolide from marine dinoflagellate Amphidinium sp.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6443265 |
MeSH ID | M0391492 |
Synonyms (4)
Synonym |
---|
amphidinolide c |
3,26,27-trioxatricyclo(21.2.1.16,9)heptacos-13-ene-4,18,21-trione, 10,11,16-trihydroxy-2-((1e,3e,5s)-5-hydroxy-4-methyl-6-methylene-1,3-decadienyl)-7,14,15,19-tetramethyl-12-methylene-, (1r,2r,6s,7r,9r,10r,11r,13e,15r,16s,19s,23r)- |
112945-21-8 |
(1r,2r,6s,7r,9r,10r,11r,13e,15r,16s,19s,23r)-10,11,16-trihydroxy-2-[(1e,3e,5s)-5-hydroxy-4-methyl-6-methylidenedeca-1,3-dienyl]-7,14,15,19-tetramethyl-12-methylidene-3,26,27-trioxatricyclo[21.2.1.16,9]heptacos-13-ene-4,18,21-trione |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (13)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.91
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.91) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |